In the second season of The Fundamentals podcast, co-hosts Kelly Malcom and Jordan Goebig talk to several leading experts from the Medical School about their fields and the fundamental questions they are trying to answer — and discover why U-M is such an amazing place for research. Six new episodes of the popular podcast were released on May 6

Dr. Jody Platt. She is an Associate Professor of Learning Health Sciences at the University of Michigan Medical School. Trained in medical sociology and health policy, her research focuses on issues at the intersection of informatics and ethics. She is interested in understanding what makes data-driven health trusted, and the pathways for earning, achieving, and sustaining trust across stakeholders. Dr. Platt is the Academy Health and ABIM Foundation Senior Scholar in Residence advising on issues of measuring and building trust.

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Six members of the University of Michigan community were inducted into the National Academies of Practice (NAP) as Distinguished Fellows in a ceremony held on March 16, 2024 in Jacksonville, Florida as part of the Annual NAP Meeting and Forum. The group includes faculty and clinicians from the University of Michigan, University of Michigan-Flint and Michigan Medicine.

Surgery patients who drink at a risky level have higher risks of complications; surgical teams could use artificial intelligence to search their records for signs that they may need to cut back.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows.

AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.

After decades of falling global maternal mortality rates, has the momentum evaporated? A new WHO report suggests just that, and Michigan Medicine researchers are urging their peers not to take their collective eye off the ball.

An interview with Dr. Steven Kunkel on research at U-M Medical School.

Learn how lived experience and research experts define wellness when living with bipolar disorder with the Heinz C. Prechter Bipolar Research Program at the University of Michigan.